January 2026's Rising Stars: Top Penny Stocks To Watch

Simply Wall St.01-20 01:05

As of January 2026, the U.S. stock market is experiencing some turbulence, with major indexes posting weekly losses amid rising Treasury yields and uncertainty surrounding Federal Reserve policies. In...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2604158076?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/5113000-choice2-main-header/1585186907028","is_english":true,"pubTime":"2026-01-20 01:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604158076","market":"hk","top_or_hot":-1,"title":"January 2026's Rising Stars: Top Penny Stocks To Watch","media":"Simply Wall St.","content":"<div>\n<p>As of January 2026, the U.S. stock market is experiencing some turbulence, with major indexes posting weekly losses amid rising Treasury yields and uncertainty surrounding Federal Reserve policies. In...</p>\n\n<a href=\"https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-zvia/zevia-pbc/news/january-2026s-rising-stars-top-penny-stocks-to-watch\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>January 2026's Rising Stars: Top Penny Stocks To Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJanuary 2026's Rising Stars: Top Penny Stocks To Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-20 01:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-zvia/zevia-pbc/news/january-2026s-rising-stars-top-penny-stocks-to-watch><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As of January 2026, the U.S. stock market is experiencing some turbulence, with major indexes posting weekly losses amid rising Treasury yields and uncertainty surrounding Federal Reserve policies. In...</p>\n\n<a href=\"https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-zvia/zevia-pbc/news/january-2026s-rising-stars-top-penny-stocks-to-watch\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CINT","symbol_name":"CI&T Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-zvia/zevia-pbc/news/january-2026s-rising-stars-top-penny-stocks-to-watch","article_id":"2604158076","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/5113000-choice2-main-header/1585186907028"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-zvia/zevia-pbc/news/january-2026s-rising-stars-top-penny-stocks-to-watch","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2604158076","pubTimestamp":1768842350,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"As of January 2026, the U.S. stock market is experiencing some turbulence, with major indexes posting weekly losses amid rising Treasury yields and uncertainty surrounding Federal Reserve policies. In this context, penny stocks—though often considered a niche investment area—can still present intriguing opportunities for growth, particularly in smaller or newer companies with strong financial foundations. This article will explore three penny stocks that stand out for their balance sheet...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"CINT":"CI&T Inc.","BK4180":"家用器具与特殊消费品","LSF":"Laird Superfood, Inc.","BK4134":"信息科技咨询与其它服务","BK4551":"寇图资本持仓","LCUT":"生活时光品牌家具","BK4509":"腾讯概念","BABB":"BAB, Inc.","BK4539":"次新股","ABOS":"Acumen Pharmaceuticals, Inc.","BK4023":"应用软件","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK4113":"食品零售","BK4531":"中概回港概念","DDL":"叮咚买菜","LX":"乐信","BK4526":"热门中概股","WDH":"水滴","BK4173":"保险经纪商","BK4139":"生物科技","LSF.AU":"L1 LONG SHORT FUND LTD","TUYA":"涂鸦智能","ZVIA":"Zevia PBC","LU0049112450.USD":"FIDELITY PACIFIC \"A\" INC","BK4505":"高瓴资本持仓","BK4212":"包装食品与肉类","CRCT":"Cricut, Inc.","MAPS":"WM Technology, Inc.","BK4166":"消费信贷","BK4209":"餐馆","BK4579":"人工智能","BK4191":"家用电器","BK4177":"软饮料","LU1235295612.USD":"FIDELITY PACIFIC \"A\" (USDHDG) INC"},"translate_title":"2026年1月的新星：最值得关注的细价股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"WDH":1,"LX":1,"LSF":1,"BABB":1,"ZVIA":1,"CINT":1,"LCUT":1,"LSF.AU":1,"MAPS":1,"TUYA":1,"DDL":1,"CRCT":1,"ABOS":1},"content_text":"As of January 2026, the U.S. stock market is experiencing some turbulence, with major indexes posting weekly losses amid rising Treasury yields and uncertainty surrounding Federal Reserve policies. In this context, penny stocks—though often considered a niche investment area—can still present intriguing opportunities for growth, particularly in smaller or newer companies with strong financial foundations. This article will explore three penny stocks that stand out for their balance sheet resilience and potential to offer significant returns despite broader market challenges.AdvertisementTop 10 Penny Stocks In The United StatesNameShare PriceMarket CapRewards & RisksDingdong (Cayman) (DDL)$2.61$559.34M✅ 4 ⚠️ 1 View Analysis >Waterdrop (WDH)$1.79$647.38M✅ 4 ⚠️ 0 View Analysis >WM Technology (MAPS)$0.825$141.09M✅ 4 ⚠️ 1 View Analysis >LexinFintech Holdings (LX)$3.00$504.79M✅ 4 ⚠️ 2 View Analysis >Tuya (TUYA)$2.25$1.36B✅ 4 ⚠️ 1 View Analysis >CI&T (CINT)$4.73$614.03M✅ 5 ⚠️ 0 View Analysis >Golden Growers Cooperative (GGRO.U)$5.00$77.45M✅ 1 ⚠️ 5 View Analysis >Cricut (CRCT)$4.31$912.62M✅ 2 ⚠️ 2 View Analysis >BAB (BABB)$0.91$6.61M✅ 2 ⚠️ 3 View Analysis >Lifetime Brands (LCUT)$3.90$88.36M✅ 3 ⚠️ 2 View Analysis >Click here to see the full list of 333 stocks from our  US Penny Stocks screener.We're going to check out a few of the best picks from our screener tool.Acumen Pharmaceuticals (ABOS)Simply Wall St Financial Health Rating: ★★★★★☆Overview: Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for Alzheimer's disease, with a market cap of $114.48 million.Operations: Acumen Pharmaceuticals, Inc. currently does not report any revenue segments as it is in the clinical-stage of developing therapies for Alzheimer's disease.Market Cap: $114.48MAcumen Pharmaceuticals is a clinical-stage biopharmaceutical company focused on Alzheimer's therapies and remains pre-revenue with no significant revenue streams. The company's debt-to-equity ratio has increased over the past five years, but it maintains more cash than total debt, providing some financial stability. Recent developments include promising research on their monoclonal antibody, Sabirnetug (ACU193), which targets toxic amyloid-beta oligomers in Alzheimer's patients. Although unprofitable with increasing losses, Acumen's cash runway extends beyond a year at current burn rates. The addition of experienced board members like Dr. George Golumbeski may bolster strategic direction amidst ongoing clinical trials.Unlock comprehensive insights into our analysis of Acumen Pharmaceuticals stock in this financial health report.Assess Acumen Pharmaceuticals' future earnings estimates with our detailed growth reports.ABOS Financial Position Analysis as at Jan 2026Laird Superfood (LSF)Simply Wall St Financial Health Rating: ★★★★★★Overview: Laird Superfood, Inc. manufactures and markets plant-based natural and functional foods in the United States, with a market cap of $35.69 million.Operations: The company's revenue is derived from its food processing segment, totaling $48.15 million.Market Cap: $35.69MLaird Superfood, Inc., with a market cap of US$35.69 million and annual revenue of US$48.15 million, has demonstrated financial resilience despite being unprofitable. The company is debt-free, with short-term assets exceeding both its short and long-term liabilities, providing a solid financial footing. Recent product expansions in its Hydrate and creamer lines could enhance revenue streams. However, Laird Superfood's stock exhibits high volatility and remains below analyst price targets despite forecasts for significant growth potential. The management team is experienced, contributing to strategic initiatives like the acquisition of Navitas LLC and securing investment from Nexus Capital.Click here to discover the nuances of Laird Superfood with our detailed analytical financial health report.Explore Laird Superfood's analyst forecasts in our growth report.LSF Debt to Equity History and Analysis as at Jan 2026Zevia PBC (ZVIA)Simply Wall St Financial Health Rating: ★★★★★☆Overview: Zevia PBC develops, markets, sells, and distributes zero sugar beverages in the United States and Canada with a market cap of $144.01 million.Operations: The company generates revenue of $162.85 million from its non-alcoholic beverage segment.Market Cap: $144.01MZevia PBC, with a market cap of US$144.01 million and annual revenue of US$162.85 million, remains unprofitable but has shown progress by reducing losses over the past five years. The company is debt-free, with short-term assets exceeding liabilities, which strengthens its financial position. Recent board changes include the addition of Suzanne Ginestro, bringing extensive marketing expertise which may bolster strategic growth initiatives. Despite significant insider selling recently and ongoing volatility in stock performance, Zevia trades at a good value relative to peers and industry benchmarks while maintaining sufficient cash runway for over three years based on current free cash flow trends.Get an in-depth perspective on Zevia PBC's performance by reading our balance sheet health report here.Understand Zevia PBC's earnings outlook by examining our growth report.ZVIA Financial Position Analysis as at Jan 2026Make It HappenExplore the 333 names from our  US Penny Stocks screener here.Ready To Venture Into Other Investment Styles? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.  This article by Simply Wall St is general in nature. We provide commentary based on historical data \n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your \n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data. \n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. \n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2604158076","isCrawlerRequest":true}